Skip to content

Intracapsular Tonsillectomy in Adults

Intracapsular vs Extracapsular Tonsillectomy. A Comparison of Treatment Methods of Recurrent and Chronic Tonsillitis in Adults: a Prospective Single-blinded Randomised Study

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03654742
Enrollment
167
Registered
2018-08-31
Start date
2019-09-27
Completion date
2028-12-30
Last updated
2025-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tonsil Disease, Tonsillitis, Tonsillitis Acute, Tonsillitis Chronic

Keywords

tonsil surgery, tonsillectomy, intracapsular, microdebrider, coblation, extracapsular, electrosurgery, electrocautery, adults

Brief summary

Comparing the classical extracapsular tonsillectomy (TE) performed with electrosurgery to intracapsular approaches (SIPT) by coblation or microdebrider. The patient group is adults with recurrent or chronic tonsillitis

Detailed description

Extracapsular tonsillectomy (TE) with monopolar electrosurgery is the most commonly used approach in adult tonsil surgery in Turku University Central Hospital, Finland. In our study setting we are comparing intracapsular tonsillectomy (subtotal/intracapsular/partial tonsillectomy (SIPT) ) as the intervention group with extracapsular tonsillectomy as the control group. SIPT is done with either coblation or microdebrider and TE with monopolar electrosurgery. Indications for surgery are recurrent tonsillitis or chronic tonsillitis. The patient group is adults (16-65 years) Safety, efficiency and cost-effectiveness are monitored in a prospective, patient-blinded and randomised study setting.

Interventions

PROCEDUREtonsillectomy

removal of tonsil tissue as described in the study arms

Sponsors

Turku University Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Patients are masked with numbers and patient records not shown to the outcomes assessor

Intervention model description

prospective, single-blinded, randomised, controlled

Eligibility

Sex/Gender
ALL
Age
16 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age 16-65 years * Planned tonsil surgery with informed consent * Recurrent or chronic tonsillitis

Exclusion criteria

* Less than 1 month old, drained quinsy * Acute hot phase tonsillitis * Previous palatine tonsil surgery * Suspicion or confirmation of malignancy * High dose analgesics consumption * Current CPAP-device usage for treatment of OSAS * Untreated gastro-esophageal reflux disease * Anticoagulative medication * Any condition of hemophilia * Pregnancy, lactation * Current or positive history of malignant disease (if still active follow-up)

Design outcomes

Primary

MeasureTime frameDescription
Post-operative recovery21 daysPain post-operatively after discharge as self-reported pain intensity over the past day. Each day is scored with the modified Brief Pain Inventory and recovery is achieved when pain score reaches preset values. Recovery speed defined as pain VAS-score 3 or less at rest; or pain VAS-score 5 or less without regular analgesics use. Daily questionnaire used: Brief Pain Inventory.

Secondary

MeasureTime frameDescription
Post-operative bleeding21 daysBleeding post-operatively at the ward or at any point during 21 days. Measured as 1-4 (1= bleeding, stopped spontaneously, no contact with staff; 2: Contact with ER, bleeding stopped without intervention; 3: Bleeding, needed intervention (packing, topical adrenalin, electrosurgical hemostasis; 4: Needed OR-time, blood transfusion, ward days
Life Quality6 monthsQuality of life as defined by the questionnaires: Tonsillectomy Outcome Inventory 14 TOI-14 preoperatively and 6 months after operation;
Residual tonsil tissue6 monthsResidual tonsil measured right after surgery is completed and at 6 months follow-up.
Analgesics use21 daysNeed for analgesics postoperatively during 21 days. Measured as number of naprometin tablets/ day and the number of tramadol-paracetamol combination tablets/day.
Throat problems5 yearsThroat problems as described by the Nordic Tonsil Surgery Register at different time points postoperatively
Life quality6 monthsQuality of life as defined by the questionnaires: Glasgow Benefit Inventory GBI at 6 months after operation.
Revision surgery5 yearsThe need of revision surgery after tonsillectomy, recorded with questionnaire: Nordic Tonsil Surgery Register

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 10, 2026